GATA-6 maintains BMP-4 and Nkx2 expression during cardiomyocyte precursor maturation.
about
myc maintains embryonic stem cell pluripotency and self-renewalmiR-145 directs intestinal maturation in zebrafishLoss of both GATA4 and GATA6 blocks cardiac myocyte differentiation and results in acardia in miceGenetically engineering self-organization of human pluripotent stem cells into a liver bud-like tissue using Gata6.Gata6 is an important regulator of mouse pancreas developmentBioengineering of injectable encapsulated aggregates of pluripotent stem cells for therapy of myocardial infarctionGATA4 and GATA5 are essential for heart and liver development in Xenopus embryos.Decoding the complex genetic causes of heart diseases using systems biologyEvolutionary conservation of glucose-dependent insulinotropic polypeptide (GIP) gene regulation and the enteroinsular axisDynamic patterning at the pylorus: formation of an epithelial intestine-stomach boundary in late fetal life.Examining the cardiac NK-2 genes in early heart development.A threshold of GATA4 and GATA6 expression is required for cardiovascular developmentOrchestrating liver development.Xenopus as a model system for vertebrate heart development.GATA-2 functions downstream of BMPs and CaM KIV in ectodermal cells during primitive hematopoiesisCardiac biomarkers: a focus on cardiac regeneration.Gata5 and Gata6 are functionally redundant in zebrafish for specification of cardiomyocytes.Defining BMP functions in the hair follicle by conditional ablation of BMP receptor IA.Identification of a Tbx1/Tbx2/Tbx3 genetic pathway governing pharyngeal and arterial pole morphogenesisCardiac progenitors and the embryonic cell cycle.Signaling involved in hair follicle morphogenesis and development.Unique functions of Gata4 in mouse liver induction and heart developmentStem Cell-Derived Exosomes, Autophagy, Extracellular Matrix Turnover, and miRNAs in Cardiac Regeneration during Stem Cell Therapy.Cardiac differentiation of pluripotent stem cells.Wnt6 signaling regulates heart muscle development during organogenesis."The good into the pot, the bad into the crop!"--a new technology to free stem cells from feeder cells.Redundancy and evolution of GATA factor requirements in development of the myocardium.Zebrafish Mef2ca and Mef2cb are essential for both first and second heart field cardiomyocyte differentiation.Influence of pub Gene Expression on Differentiation of Mouse Embryonic Stem Cells into Derivatives of Ecto-, Meso-, and Endoderm in vitro.The Aplnr GPCR regulates myocardial progenitor development via a novel cell-non-autonomous, Gα(i/o) protein-independent pathway.Common genetic control of haemangioblast and cardiac development in zebrafish.HIF-1alpha signaling upstream of NKX2.5 is required for cardiac development in Xenopus.Heart function and thoracic aorta gene expression profiling studies of ginseng combined with different herbal medicines in eNOS knockout mice.Genome-wide transcriptomics analysis identifies sox7 and sox18 as specifically regulated by gata4 in cardiomyogenesis.Different requirements for GATA factors in cardiogenesis are mediated by non-canonical Wnt signaling.Wnt/beta-catenin signalling regulates cardiomyogenesis via GATA transcription factors.Genome-wide transcriptomics analysis of genes regulated by GATA4, 5 and 6 during cardiomyogenesis in Xenopus laevis.Isolated skeletal malformations in a child with a small mosaic ring microduplication of 18 p11.21q11.2: genotype-phenotype correlations.smarce1 mutants have a defective endocardium and an increased expression of cardiac transcription factors in zebrafish
P2860
Q24596179-4949FC47-1E5E-4724-A5C0-F48B73567211Q24650959-0D8B3C02-395E-42C3-8052-87CA2A90DA47Q24657983-EC4AC47B-C642-4ED1-B180-79D1C2321C2DQ27336171-2105A342-B959-41E5-A62C-294EB7EEDDC8Q28505084-05A9ED81-EA31-41FE-BA2A-4F0F1F03B561Q30827483-57B2E7B7-C4D5-4BF4-885E-37CB64AE6DB1Q33355646-7CA4F362-BCD8-43A8-8EA7-B3955E711716Q33639681-24174FD1-8B32-4A5C-B101-F5C48B002F59Q34079561-EC6C7B7A-8580-4E5D-9B8A-40E478C8CBADQ34082932-50FC337A-BF0C-4E1A-9AF4-E1E98F75CFE5Q34308498-3E78AEC0-6DA1-4B74-B92D-A95FF496CE61Q34983873-C5EC6BD9-E134-422C-9FC4-98668D7FA111Q35791195-0B8BB1C4-4280-4E74-8117-3C7AF33A0891Q35793616-66D24451-0BE2-4075-8A9E-8E7871F519CFQ36103531-40D5DAD7-06E7-43F1-A398-B42AE5E6F70AQ36307694-E68D9A51-4D22-4F4E-BA7D-0687795F8F04Q36319329-744407CB-B5C0-44CD-98FA-8C9EE5897B91Q36324810-566AFDF6-2911-4ECC-ACD7-524092A354D1Q36379778-4B83536D-FF8E-4A4B-8D57-32118933B094Q36915882-6113F24E-8452-4AD9-BF8C-383BE0AD7E19Q37535695-72E1EE52-1005-448A-9D6F-DE6A52DDC833Q38548499-0E630B1E-677F-4025-AC0D-FF337FD2226CQ38997197-54685283-92C0-4DD6-9BB4-29059C8357CBQ39747622-1CF8963D-F8D2-4DEC-8864-4BDD7EC3AC6FQ41333664-1F5C5E6A-B7F9-4A9C-82B1-02DE37EBB30DQ41761178-1346E123-FB43-4264-8CC0-EFCB9613D94BQ41790172-51E773F1-24EC-4363-B6A3-88EA1F2BFFE9Q41962292-61139CA4-8BCD-402E-84AB-C16F0BA43446Q42104555-5B8A7812-EBB1-41FF-BBFA-7B9A880007D2Q42175826-6C21A56D-3747-431F-BD0C-E6586F89EA09Q43065848-8D4129F4-4CBE-489A-BE23-E45B0B782E97Q45875521-A0D316E6-B6CF-4731-83AA-44EAE1DD2BC0Q47128850-44A70B2F-5BE0-4A8F-AC05-05EF8795B86EQ49923246-3BCC6281-C3AD-4120-A98B-F535A15CF258Q51889240-8356741F-8AD0-4DCD-9C21-44E24FD75D45Q51910286-D4B564D5-11D7-4989-B8A8-013E04AD9B4DQ55063226-82431FAF-40CC-482B-BB8A-762A72CBC6D0Q55500254-7FDBE23E-4772-4D09-B72A-F0726BB1DDB0Q58603355-B541BCA6-2AB4-4374-8A7D-AEE06E747CAB
P2860
GATA-6 maintains BMP-4 and Nkx2 expression during cardiomyocyte precursor maturation.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
GATA-6 maintains BMP-4 and Nkx2 expression during cardiomyocyte precursor maturation.
@en
type
label
GATA-6 maintains BMP-4 and Nkx2 expression during cardiomyocyte precursor maturation.
@en
prefLabel
GATA-6 maintains BMP-4 and Nkx2 expression during cardiomyocyte precursor maturation.
@en
P2093
P2860
P356
P1433
P1476
GATA-6 maintains BMP-4 and Nkx2 expression during cardiomyocyte precursor maturation.
@en
P2093
Abigail Gibson
Roger Patient
Tessa Peterkin
P2860
P304
P356
10.1093/EMBOJ/CDG400
P407
P577
2003-08-01T00:00:00Z